Companies / Netherlands
DSM Looks To Disassociate Anti-Infective Division
June 2007 | Company News AlertUnderlining the trend for Western European active pharmaceutical ingredient (API) manufacturers to shift operations to Asia, Dutch firm DSM is seeking to carve-out its anti-infective division, ideally forming a partnership with a local player in the region. Separately, the production of side chains will continue to be shifted from the DSM site in Spain to China. The company hopes that by employing this strategy, DSM Anti-Infectives will report sustainable profits from 2008. BMI endorses this approach and fully expects DSM to achieve its
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
